Sort
15,273 grants matching “antimicrobial resistance”
Treating drug-resistant infections of burn wounds with an optimized antimicrobial peptide
$314,363Sven-Ulrik Gorr · Gavia Bio, Llc · R41 · FY2025 · AI
N-terminal acylation of Lipoproteins in Firmicutes
$314,337Timothy C. Meredith · Pennsylvania State University, The · R01 · FY2019 · GM
N-terminal acylation of Lipoproteins in Firmicutes
$314,236Timothy C. Meredith · Pennsylvania State University, The · R01 · FY2020 · GM
NOVEL METHODS FOR DISCOVERY OF ANTI-MICROBIALS
$314,200Northeastern University · R21 · FY2005 · AI
N-terminal acylation of Lipoproteins in Firmicutes
$314,133Timothy C. Meredith · Pennsylvania State University, The · R01 · FY2021 · GM
Spin-Labeled Peptide Antibiotics
$314,116Jimmy Feix · Medical College Of Wisconsin · R01 · FY2010 · GM
UVPD Mass Spectrometry of Protein Complexes
$314,087Jennifer S Brodbelt · University Of Texas At Austin · R01 · FY2020 · GM
N-terminal acylation of Lipoproteins in Firmicutes
$314,025Timothy C. Meredith · Pennsylvania State University, The · R01 · FY2022 · GM
Development of antifungal drug resistance in the oral environment over the course of HIV infection
$314,000Laura Brunengraber Goodman · Cornell University · R03 · FY2024 · DE
Molecular pathways involved in TLR11 mediated IL-12 production by dendritic cells
$314,000Felix Yarovinsky · Ut Southwestern Medical Center · R21 · FY2008 · AI
ELECTRON MICROSCOPY OF MEMBRANE PROTEINS(RMI)
$313,834Ronald A Milligan · Scripps Research Institute, The · R01 · FY2007 · GM
Antimicrobial Peptides and their Synthetic Mimics - Investigating the Mechanism o
$313,788David Gidalevitz · Illinois Institute Of Technology · R01 · FY2009 · AI
Structure and Mechanism of Metalloregulatory Proteins
$313,772David P. Giedroc · Trustees Of Indiana University · R01 · FY2010 · GM
Impact of Hand Hygiene Guideline on Infections and Costs
$313,565Columbia University Health Sciences · R01 · FY2004 · NR
Controlling the Source of Inflammatory Signaling in a Burn Model
$313,436Saman Arbabi · University Of Washington · R01 · FY2011 · GM
Controlling the Source of Inflammatory Signaling in a Burn Model
$313,436Saman Arbabi · University Of Washington · R01 · FY2012 · GM
Controlling Bacterial Amyloid Formation and the Influence of Curli Subunits on Pathogenic Alpha-synuclein Aggregation
$313,399Matthew R Chapman · University Of Michigan At Ann Arbor · R01 · FY2025 · GM
Broad spectrum Tricyclics GyrB, ParE inhibitors for antibacterial applications
$313,384Kenneth Bartizal · Rbhs-New Jersey Medical School · U19 · FY2018 · AI
NITRIC OXIDE CYTOTOXICITY IN SALMONELLOSIS
$313,073University Of Washington · R01 · FY2001 · AI
Collaborative Research: Polymeric Drug Delivery Systems and Biofilms in the Lung
$313,014Gerald W Young · University Of Akron · R01 · FY2011 · GM
S. mutans: Its mutacin Antibiotic
$312,543Fengxia Qi · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2007 · DE
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases
$312,440John McLeod Griffiss · Icon Government And Public Health Solutions, Inc. · N01 · FY2017 · AI
Nasal carriage of S. aureus: host-pathogen interactions
$312,419Alexander M Cole · University Of Central Florida · R01 · FY2007 · AI
Enzymology of N5-CAIR Synthetase
$312,404Steven M Firestine · Wayne State University · R01 · FY2012 · GM
Enzymology of N5-CAIR Synthetase
$312,404Steven M Firestine · Wayne State University · R01 · FY2011 · GM